Posts Tagged COVID-19

A new study shows monoclonal antibodies and oral antiviral drugs were not used as much as would be expected given the high risk of resident populations.

A new program combines improv theater techniques with coaching on motivation theory to help health care workers guide patients during conversations about vaccination.

The inexpensive, portable device could help safeguard against future pandemics and detect viruses and infections in underserved populations.

Pre-existing immunity to the common cold was thought to protect people from COVID-19. But new evidence suggests that sometimes the opposite can happen.

A study led by researchers at the University of Toronto and coauthored by Rochester’s Bonne Le, showed that people who lived with family during COVID-19 had better mental health outcomes than people living alone.

Medical Center researchers have found that mothers with both disease-acquired and mRNA vaccination-acquired immunity to COVID-19 produced breast milk with active SARS-CoV-2 antibodies.

On her blog, Simon Business School Dean Sevin Yeltekin addresses six key questions related to the rise of inflation in the post-COVID-19 business world.

Rochester biologists propose that disrupted interactions between the proteins that closely evolve with the ACE2 receptor may play a role in COVID-19 complications.

For Rochester economist Lisa Kahn, whose research focuses primarily on labor economics, the past year and a half has been nothing short of astonishing. She explains why.

The University of Rochester Medical Center and Rochester General Hospital are two of only 12 sites nationally that are testing Pfizer and BioNTech’s new mRNA flu vaccine.